小型RNA:RNAの干渉は治療のために利用できますか?
1Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Lancet (London, England)
|October 31, 2003
まとめ
RNA干渉 (RNAi) は,小さな干渉RNAs (siRNAs) が遺伝子治療に有望であることを示す,遺伝子サイレンシングのための強力な方法を提供します. 臨床応用には,配達と安定性のさらなる開発が必要である.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- バイオテクノロジー バイオテクノロジー
背景:
- RNA干渉 (RNAi) は,遺伝子サイレンシングの自然なプロセスである.
- 小型の干渉RNA (siRNAs) は RNAiの重要な効果因子であり,配列特異的な遺伝子ノックダウンを可能にします.
- RNAiは,ウイルス感染症,がん,遺伝疾患における治療用途のために研究されている.
研究 の 目的:
- 遺伝子機能研究および治療応用のためのRNA干渉 (RNAi) の可能性を調査する.
- 標的型遺伝子サイレンシングのための小さな干渉RNA (siRNA) の使用を調査する.
- 癌に関連する経路に関与する遺伝子ファミリーを研究することによって,新しい治療標的を特定する.
主な方法:
- 配列特異的な遺伝子抑制のための合成小干渉RNA (siRNAs) を利用する.
- 効率的なsiRNAおよび短いヘアピンRNA (shRNA) 発現のためにプラズミドおよびウイルスベクターを使用します.
- 脱ユビキチン化酵素など,特定の遺伝子ファミリーを抑制するためのRNA干渉ベクトルの開発.
主要な成果:
- siRNAsが内生的な遺伝子発現を選択的に抑制することが示された.
- シリンドロマトーシス腫瘍抑制遺伝子 (CYLD) をNF-kappaBの活性化とアポトーシス抵抗の調節剤として特定した.
- プラズミドおよびウイルスベクトルベースのshRNA発現システムを用いた安定した遺伝子発現抑制をin vitroおよびin vivoで示した.
結論:
- RNAiは,特にsiRNAsとshRNAsを使用して,遺伝子機能分析と潜在的な治療介入のための強力なツールを提供します.
- siRNA/shRNAを標的組織に効率的かつ安定的に配送することは,臨床トランスレーションの重要な分野です.
- 配送システムのさらなる研究と精錬は,RNAiベースの治療法を活用した臨床試験への道を開いている.
関連する概念動画
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...